Healthcare
Live Price
Offline$0.0002
+0.00% today
1Y Change
-99.78%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Yulong Eco-Materials Limited (YECO) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 99.8% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +264.7%, EPS growth of +75.7%, a dividend yield of 0.0%. What stands out right now is revenue +264.7%, EPS +75.7%, free cash flow +96.2% with operating margin -38.8% and ROIC 6.1%. Valuation sits in the middle of the pack at price/sales 4.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines YECO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
YECO
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
YECO Max Drawdown
-99.80%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for YECO and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
-$99.0K
+74.5% YoY
Free Cash Flow
$97.7K
+100.5% YoY
Revenue Growth
+264.7%
EPS Growth
+75.7%
Gross Margin
0.0%
Net Margin
-38.8%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 178K | 49K | 0 | 119K | 0 |
| Gross Profit | 0 | 49K | 0 | 119K | 0 |
| Operating Income | -299K | -483K | -590K | -24K | -99K |
| EBITDA | -299K | -1M | -21M | -151K | -99K |
| Net Income | -299K | -1M | -21M | -388K | -99K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 16 | 127K | 335K | 600K | 103K |
| Total Assets | 475K | 432K | 11M | 31M | 9M |
| Total Liabilities | 2M | 2M | 25M | 24M | 1M |
| Shareholder Equity | -2M | -2M | -14M | 7M | 8M |
| Total Debt | 2M | 1M | 23M | 22M | 0 |
| Net Debt | 2M | 1M | 22M | 21M | -103K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
98K
-86.0% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
98K
+100.5% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
-38.8%
Net Margin
-38.8%
ROE
1.7%
Debt / Equity
-0.74x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.